# OnCo record imp1734 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/imp1734/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "imp1734" ;
  schema:name "IMP1734"@en ;
  schema:alternateName "EIK1003"@en ;
  schema:description "EIK1003, formerly IMP1734, is an experimental pill that blocks the PARP1 DNA-repair enzyme."@en ;
  schema:url <https://onco.cc/drugs/imp1734/> ;
  schema:dateModified "2026-10-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=IMP1734>, <https://clinicaltrials.gov/study/NCT06253130>, <https://www.eikontx.com/news/eikon-therapeutics-to-provide-corporate-updates-at-the-42nd-annual-j-p-morgan-healthcare-conference/> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest", "registry-only" ;
  onco:modality "Small-molecule inhibitor" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:targets <https://onco.cc/targets/parp/> ;
  onco:companies <https://onco.cc/companies/eikon-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct06253130/> .